Azhar Kaka - Adcock Ingram Head Division
| AIP Stock | 6,500 199.00 2.97% |
Executive
Azhar Kaka is Head Division of Adcock Ingram Holdings
| Phone | 27 11 635 0000 |
| Web | https://www.adcock.co.za |
Adcock Ingram Management Efficiency
The company has return on total asset (ROA) of 0.0891 % which means that it generated a profit of $0.0891 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1613 %, meaning that it generated $0.1613 on every $100 dollars invested by stockholders. Adcock Ingram's management efficiency ratios could be used to measure how well Adcock Ingram manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | EXECUTIVE Age | ||
| Pieter Preez | Shoprite Holdings | N/A | |
| LeeAnn Herbst | Ascendis Health | 47 | |
| Riyas Fadal | Ascendis Health | 48 | |
| Marnus Sonnekus | Ascendis Health | N/A | |
| CA BACC | Shoprite Holdings | 46 | |
| Chris Swanepoel | Ascendis Health | N/A | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0891 |
Adcock Ingram Holdings Leadership Team
Elected by the shareholders, the Adcock Ingram's board of directors comprises two types of representatives: Adcock Ingram inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adcock. The board's role is to monitor Adcock Ingram's management team and ensure that shareholders' interests are well served. Adcock Ingram's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adcock Ingram's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dorette Neethling, CFO Director | ||
| Mahlatse Phalafala, Company Legal | ||
| NDip MBA, Managing Hospital | ||
| Tobie Krige, Managing Distribution | ||
| Azhar Kaka, Head Division | ||
| BPharm CA, CEO Director | ||
| BCom Pharm, Managing Prescription | ||
| Basadifeela Letsoalo, Exec Director | ||
| Nkosinathi Mthethwa, Public Exec | ||
| R Essa, Corp Director |
Adcock Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adcock Ingram a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0891 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 8.21 B | |||
| Shares Outstanding | 161.76 M | |||
| Shares Owned By Insiders | 55.23 % | |||
| Shares Owned By Institutions | 17.67 % | |||
| Price To Book | 1.57 X | |||
| Price To Sales | 0.95 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Adcock Stock
Adcock Ingram financial ratios help investors to determine whether Adcock Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Adcock with respect to the benefits of owning Adcock Ingram security.